| Joseph M Pyles, MD | |
|
17525 River Rd, Noblesville, IN 46062-8528 | |
| (317) 773-7711 | |
| Not Available |
| Full Name | Joseph M Pyles |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 33 Years |
| Location | 17525 River Rd, Noblesville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255330981 | NPI | - | NPPES |
| 100199530A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 01040695A (Indiana) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 01040695A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverview Health | Noblesville, IN | Hospital |
| Marion General Hospital | Marion, IN | Hospital |
| St Vincent Heart Center | Indianapolis, IN | Hospital |
| Ascension St Vincent Mercy | Elwood, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that The New England Journal of Medicine (NEJM) has published in its September 3rd edition, the Company's pivotal CORD I Phase III clinical trial of XIAFLEX (collagenase clostridium histolyticum) a novel, first-in-class, biologic for the nonsurgical treatment of Dupuytren's contracture.
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
The four out of ten women who use antibiotics during pregnancy can breathe easy, as a comprehensive new study shows that the two most often prescribed drugs have no adverse outcome on the child's physical development.
A recent study investigates histone mimicry as a mechanism by SARS-CoV-2 for disrupting epigenetic regulation to evade host cell responses to infection.
› Verified 8 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that The New England Journal of Medicine (NEJM) has published in its September 3rd edition, the Company's pivotal CORD I Phase III clinical trial of XIAFLEX (collagenase clostridium histolyticum) a novel, first-in-class, biologic for the nonsurgical treatment of Dupuytren's contracture.
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
The four out of ten women who use antibiotics during pregnancy can breathe easy, as a comprehensive new study shows that the two most often prescribed drugs have no adverse outcome on the child's physical development.
A recent study investigates histone mimicry as a mechanism by SARS-CoV-2 for disrupting epigenetic regulation to evade host cell responses to infection.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph M Pyles, MD 17525 River Rd, Noblesville, IN 46062-8528 Ph: () - | Joseph M Pyles, MD 17525 River Rd, Noblesville, IN 46062-8528 Ph: (317) 773-7711 |
News Archive
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that The New England Journal of Medicine (NEJM) has published in its September 3rd edition, the Company's pivotal CORD I Phase III clinical trial of XIAFLEX (collagenase clostridium histolyticum) a novel, first-in-class, biologic for the nonsurgical treatment of Dupuytren's contracture.
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
The four out of ten women who use antibiotics during pregnancy can breathe easy, as a comprehensive new study shows that the two most often prescribed drugs have no adverse outcome on the child's physical development.
A recent study investigates histone mimicry as a mechanism by SARS-CoV-2 for disrupting epigenetic regulation to evade host cell responses to infection.
› Verified 8 days ago
Dr. Sarah Catherine Perryman, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5540 Pebble Village Ln Ste 200, Noblesville, IN 46062 Phone: 317-900-4060 Fax: 317-900-4698 | |
Lori A Brame, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 395 Westfield Rd, Suite D, Noblesville, IN 46060 Phone: 317-776-3520 Fax: 317-776-3522 | |
Raj N Nagaraj, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 395 Westfield Rd Ste D, Noblesville, IN 46060 Phone: 317-776-3520 Fax: 317-776-3522 | |
Bruce F Schilt, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 17525 River Rd, Noblesville, IN 46062 Phone: 317-773-7711 Fax: 317-776-6561 | |
Dr. Navneet Lather, MD, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 17525 River Rd, Noblesville, IN 46062 Phone: 317-773-7711 | |
Agnes J Schrader, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 165 Sheridan Rd, Noblesville, IN 46060 Phone: 317-773-0363 Fax: 317-770-8910 |